These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3767346)

  • 1. Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.
    Czinn S; Carr H; Aronoff S
    Antimicrob Agents Chemother; 1986 Aug; 30(2):328-9. PubMed ID: 3767346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA; Lo Bue AM; Chisari G; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(1-6):16-24. PubMed ID: 3500081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T; Neu HC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
    Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of Campylobacter pyloridis to antibiotics].
    Freland C; Massoubre B; Drugeon HB
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):809-12. PubMed ID: 3309819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
    Jorgensen JH; Redding JS; Howell AW
    Antimicrob Agents Chemother; 1986 May; 29(5):921-2. PubMed ID: 3488019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of roxithromycin: a laboratory evaluation.
    Chantot JF; Bryskier A; Gasc JC
    J Antibiot (Tokyo); 1986 May; 39(5):660-8. PubMed ID: 3733515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
    McNulty CA; Dent J; Wise R
    Antimicrob Agents Chemother; 1985 Dec; 28(6):837-8. PubMed ID: 2935076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
    Delaforge M; Sartori E; Mansuy D
    Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
    Dette GA; Knothe H; Koulen G
    Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.
    Labro MT; Amit N; Babin-Chevaye C; Hakim J
    Antimicrob Agents Chemother; 1986 Jul; 30(1):137-42. PubMed ID: 3019233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.
    Misu T; Arai S; Furukawa M; Yamamoto Y; Miyazaki T
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1843-5. PubMed ID: 3124740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory and lethal activities of rosaramicin, erythromycin, and clindamycin against Campylobacter fetus subsp jejuni and intestinalis.
    Smith JA; Isaac-Renton JL; Jellett JF; Chow AW; Ngui-Yen J
    Am J Vet Res; 1983 Aug; 44(8):1605-6. PubMed ID: 6625312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.
    Goodwin CS; Blake P; Blincow E
    J Antimicrob Chemother; 1986 Mar; 17(3):309-14. PubMed ID: 3700291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.